Melatonin in melasma

Phase 3

Recruiting

• Conditions: Melasma.; L81.1; Chloasma

• Registration Number: IRCT20090808002306N10
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 22 July 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 44

Inclusion Criteria

Obtaining the intensity and melasma area index score (massi score) 10
Not using other topical treatments at least two weeks before participating in the research project
No use of systemic steroids for the treatment of melasma for at least one month before participating in the research project
Not using other treatment methods such as laser to treat melasma for at least 3 months before participating in the research project
Consent and informed consent of the person to enter this research project

Exclusion Criteria

Patients non-compliance to the study protocol
Utilization of other anti melasma treatments
Patients' personal will to the exclusion from the study

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Melasma score in Masi index. Timepoint: Measuring melasma recovery before treatment and 4 weeks after treatment. Method of measurement: Masi measurement index.